{{'Search' | translate}}
 

SeeBlue Plus2 Prestained Standard

Company: Thermo Fisher Scientific
Catalog#: LC5925
Bio-protocol()
Company-protocol()
Other protocol()

Analysis of Direct Interaction between Viral DNA-binding Proteins by Protein Pull-down Co-immunoprecipitation Assay
Author:
Date:
2018-01-05
[Abstract]  This protocol analyzes the direct interaction between two DNA-binding proteins by pull-down co-immunoprecipitation. One of the proteins is overexpressed in E. coli as HA-tagged recombinant protein and cell-free extracts are immunoprecipitated in HA-affinity resin. Cell extracts are treated with nuclease to degrade DNA and RNA, which rules out nucleic acid-mediated indirect interaction. Then, a second immunoprecipitation step is performed using the purified putative partner protein. Co-immunoprecipitated proteins can be detected either by Coomassie Blue staining and/or Western blotting (WB) if a specific antibody is available. Moreover, many DNA/RNA binding proteins are highly electropositive, which can hinder WB under standard conditions, as has been shown in histones and ... [摘要]  该协议通过下拉共免疫沉淀分析两种DNA结合蛋白之间的直接相互作用。其中一种蛋白在E中过表达。如HA标记的重组蛋白和无细胞提取物在HA亲和树脂中免疫沉淀。用核酸酶处理细胞提取物以降解DNA和RNA,这排除了核酸介导的间接相互作用。然后,使用纯化的推定的配偶体蛋白进行第二次免疫沉淀步骤。如果特异性抗体可用,可以通过考马斯蓝染色和/或Western印迹(WB)检测免疫共沉淀蛋白质。此外,许多DNA / RNA结合蛋白具有高度正电性,在标准条件下可阻碍WB,正如组蛋白和组蛋白样蛋白所示。在这种情况下,我们表明,假定的合作伙伴的高等电点导致转移不良。提示麻烦WB提供高正电荷DNA结合蛋白的转移。


【背景】共免疫沉淀是分析蛋白质 - 蛋白质相互作用(PPI)的常用方法。许多共免疫沉淀方案使用细菌表达的蛋白质。然而,细胞提取物的使用不排除由第三种蛋白介导的间接相互作用,或者在DNA / RNA结合蛋白的情况下介导核酸。

乙型病毒Bam35(B35TP)的末端蛋白含有保守的酪氨酸194,其提供OH基团以在蛋白质引发的DNA复制期间锚定病毒基因组的第一个5'-dTMP。此外,B35TP具有很强的DNA结合能力,与许多DNA结合蛋白一样,它具有非常高的等电点(约10.6),这影响其体外稳定性和功能(Berjón-Otero 等),2016)。 ...

Immunoprecipitation of Cell Surface Proteins from Gram-negative Bacteria
Author:
Date:
2017-05-05
[Abstract]  The meningococcus (Neisseria meningitidis) remains an important threat to human health worldwide. This Gram-negative bacterium causes elevated disabilities and mortality in infected individuals. Despite several available vaccines, currently there is no universal vaccine against all circulating meningococcal strains (Vogel et al., 2013). Herein, we describe a new protocol that is capable of identifying only cell surface exposed proteins that play a role in immunity, providing this research field with a more straightforward approach to identify novel vaccine targets. Even though N. meningitidis is used as a model in the protocol herein described, this protocol can be used for any Gram-negative bacteria provided modifications and optimizations are carried out to ... [摘要]  脑膜炎球菌(脑膜炎奈瑟氏球菌)仍然是全球人类健康的重大威胁。这种革兰氏阴性细菌导致感染个体的残疾和死亡率升高。尽管有几种可用的疫苗,目前还没有针对所有循环脑膜炎球菌菌株的通用疫苗(Vogel等人,2013)。在这里,我们描述了一种能够识别仅在细胞表面暴露的蛋白质在免疫中发挥作用的新方案,为该研究领域提供了一种更直接的方法来鉴定新的疫苗靶标。即使使用脑膜炎奈瑟氏球菌作为本文所述方案中的模型,该方案可用于任何革兰氏阴性细菌,提供修饰和优化以使其适应不同的细菌和疾病特征(例如薄膜脆性,生长方法,血清抗体水平,等等)。


背景 尝试开发针对N型的新型疫苗。脑膜炎脑膜炎常常依赖于2D SDS-PAGE(二维十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳)和蛋白质印迹,随后MS(质谱)(Wheeler等人,2007))。然而,这种方法采用全细胞裂解物,鉴定出不具有疫苗潜力的大量蛋白质(Mendum等人,2009)。因此,我们旨在开发一种能够鉴别可能在免疫中起重要作用的细胞表面暴露蛋白质的方法。简言之,我们的方案包括生长感兴趣的病原体,用免疫个体的血清免疫沉淀表面抗原,并通过液相色谱 - ...

Comments